nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—migraine—epilepsy syndrome	0.402	1	CtDrD
Propranolol—Methocarbamol—Felbamate—epilepsy syndrome	0.123	0.789	CrCrCtD
Propranolol—CYP2C19—epilepsy syndrome	0.0502	0.44	CbGaD
Propranolol—CYP2D6—epilepsy syndrome	0.0372	0.327	CbGaD
Propranolol—Indecainide—Oxcarbazepine—epilepsy syndrome	0.033	0.211	CrCrCtD
Propranolol—ABCB1—epilepsy syndrome	0.0266	0.233	CbGaD
Propranolol—CYP3A5—Oxcarbazepine—epilepsy syndrome	0.00698	0.0327	CbGbCtD
Propranolol—CYP1A1—Propofol—epilepsy syndrome	0.00611	0.0286	CbGbCtD
Propranolol—CYP3A7—Carbamazepine—epilepsy syndrome	0.00585	0.0274	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Carbamazepine—epilepsy syndrome	0.00585	0.0274	CbGbCtD
Propranolol—CYP1A1—Phenobarbital—epilepsy syndrome	0.00584	0.0274	CbGbCtD
Propranolol—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00563	0.0264	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Phenytoin—epilepsy syndrome	0.00524	0.0246	CbGbCtD
Propranolol—CYP3A7—Phenytoin—epilepsy syndrome	0.00524	0.0246	CbGbCtD
Propranolol—CYP2C19—Felbamate—epilepsy syndrome	0.00524	0.0245	CbGbCtD
Propranolol—CYP2C19—Trimethadione—epilepsy syndrome	0.00524	0.0245	CbGbCtD
Propranolol—ABCB1—Levetiracetam—epilepsy syndrome	0.00497	0.0233	CbGbCtD
Propranolol—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00492	0.0231	CbGbCtD
Propranolol—CYP3A7—Phenobarbital—epilepsy syndrome	0.00467	0.0219	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Phenobarbital—epilepsy syndrome	0.00467	0.0219	CbGbCtD
Propranolol—CYP3A7—Midazolam—epilepsy syndrome	0.00461	0.0216	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Midazolam—epilepsy syndrome	0.00461	0.0216	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Diazepam—epilepsy syndrome	0.00443	0.0208	CbGbCtD
Propranolol—CYP3A7—Diazepam—epilepsy syndrome	0.00443	0.0208	CbGbCtD
Propranolol—CYP3A5—Carbamazepine—epilepsy syndrome	0.00438	0.0206	CbGbCtD
Propranolol—CYP2C19—Clobazam—epilepsy syndrome	0.00427	0.02	CbGbCtD
Propranolol—CYP3A5—Phenytoin—epilepsy syndrome	0.00393	0.0184	CbGbCtD
Propranolol—CYP2C19—Carbamazepine—epilepsy syndrome	0.00354	0.0166	CbGbCtD
Propranolol—CYP3A5—Phenobarbital—epilepsy syndrome	0.00351	0.0164	CbGbCtD
Propranolol—CYP3A5—Midazolam—epilepsy syndrome	0.00346	0.0162	CbGbCtD
Propranolol—ABCB1—Clobazam—epilepsy syndrome	0.00344	0.0161	CbGbCtD
Propranolol—CYP3A5—Diazepam—epilepsy syndrome	0.00332	0.0156	CbGbCtD
Propranolol—ABCB1—Lamotrigine—epilepsy syndrome	0.00331	0.0155	CbGbCtD
Propranolol—CYP2C19—Primidone—epilepsy syndrome	0.0033	0.0155	CbGbCtD
Propranolol—CYP1A2—Carbamazepine—epilepsy syndrome	0.00326	0.0153	CbGbCtD
Propranolol—CYP2C19—Phenytoin—epilepsy syndrome	0.00317	0.0149	CbGbCtD
Propranolol—CYP1A2—Primidone—epilepsy syndrome	0.00305	0.0143	CbGbCtD
Propranolol—CYP2C19—Propofol—epilepsy syndrome	0.00296	0.0139	CbGbCtD
Propranolol—ABCB1—Carbamazepine—epilepsy syndrome	0.00285	0.0134	CbGbCtD
Propranolol—CYP2C19—Phenobarbital—epilepsy syndrome	0.00283	0.0133	CbGbCtD
Propranolol—CYP1A2—Propofol—epilepsy syndrome	0.00273	0.0128	CbGbCtD
Propranolol—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00272	0.0128	CbGbCtD
Propranolol—CYP2C19—Diazepam—epilepsy syndrome	0.00268	0.0126	CbGbCtD
Propranolol—CYP3A5—Valproic Acid—epilepsy syndrome	0.00262	0.0123	CbGbCtD
Propranolol—CYP2C19—Zonisamide—epilepsy syndrome	0.00262	0.0123	CbGbCtD
Propranolol—CYP1A2—Phenobarbital—epilepsy syndrome	0.00261	0.0122	CbGbCtD
Propranolol—ABCB1—Phenytoin—epilepsy syndrome	0.00256	0.012	CbGbCtD
Propranolol—CYP3A4—Felbamate—epilepsy syndrome	0.00253	0.0119	CbGbCtD
Propranolol—CYP3A4—Trimethadione—epilepsy syndrome	0.00253	0.0119	CbGbCtD
Propranolol—CYP1A2—Diazepam—epilepsy syndrome	0.00247	0.0116	CbGbCtD
Propranolol—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00238	0.0112	CbGbCtD
Propranolol—ABCB1—Phenobarbital—epilepsy syndrome	0.00228	0.0107	CbGbCtD
Propranolol—ABCB1—Midazolam—epilepsy syndrome	0.00225	0.0105	CbGbCtD
Propranolol—CYP2D6—Propofol—epilepsy syndrome	0.00225	0.0105	CbGbCtD
Propranolol—ABCB1—Diazepam—epilepsy syndrome	0.00216	0.0101	CbGbCtD
Propranolol—CYP3A4—Clonazepam—epilepsy syndrome	0.00215	0.0101	CbGbCtD
Propranolol—CYP2C19—Valproic Acid—epilepsy syndrome	0.00211	0.00991	CbGbCtD
Propranolol—CYP3A4—Clobazam—epilepsy syndrome	0.00206	0.00967	CbGbCtD
Propranolol—CYP1A2—Valproic Acid—epilepsy syndrome	0.00195	0.00914	CbGbCtD
Propranolol—CYP2C19—Topiramate—epilepsy syndrome	0.00191	0.00894	CbGbCtD
Propranolol—CYP3A4—Rufinamide—epilepsy syndrome	0.00175	0.00823	CbGbCtD
Propranolol—CYP3A4—Carbamazepine—epilepsy syndrome	0.00171	0.00802	CbGbCtD
Propranolol—CYP3A4—Primidone—epilepsy syndrome	0.0016	0.00748	CbGbCtD
Propranolol—CYP3A4—Phenytoin—epilepsy syndrome	0.00153	0.00719	CbGbCtD
Propranolol—CYP3A4—Propofol—epilepsy syndrome	0.00143	0.00671	CbGbCtD
Propranolol—CYP3A4—Phenobarbital—epilepsy syndrome	0.00137	0.00641	CbGbCtD
Propranolol—CYP3A4—Acetazolamide—epilepsy syndrome	0.00137	0.00641	CbGbCtD
Propranolol—CYP3A4—Midazolam—epilepsy syndrome	0.00135	0.00632	CbGbCtD
Propranolol—CYP3A4—Diazepam—epilepsy syndrome	0.0013	0.00607	CbGbCtD
Propranolol—CYP3A4—Zonisamide—epilepsy syndrome	0.00126	0.00593	CbGbCtD
Propranolol—CYP3A4—Valproic Acid—epilepsy syndrome	0.00102	0.00479	CbGbCtD
Propranolol—CYP3A4—Topiramate—epilepsy syndrome	0.000922	0.00432	CbGbCtD
Propranolol—HTR1B—telencephalic ventricle—epilepsy syndrome	0.000651	0.103	CbGeAlD
Propranolol—HTR1A—telencephalic ventricle—epilepsy syndrome	0.000525	0.0834	CbGeAlD
Propranolol—HTR1B—ganglion—epilepsy syndrome	0.000405	0.0643	CbGeAlD
Propranolol—HTR1A—ganglion—epilepsy syndrome	0.000327	0.0519	CbGeAlD
Propranolol—Ranolazine—SCN9A—epilepsy syndrome	0.000271	0.184	CrCbGaD
Propranolol—HTR1A—hindbrain—epilepsy syndrome	0.000248	0.0394	CbGeAlD
Propranolol—HTR1B—brainstem—epilepsy syndrome	0.000176	0.028	CbGeAlD
Propranolol—HTR1B—forebrain—epilepsy syndrome	0.00017	0.027	CbGeAlD
Propranolol—ADRB1—forebrain—epilepsy syndrome	0.00016	0.0254	CbGeAlD
Propranolol—HTR1B—telencephalon—epilepsy syndrome	0.000156	0.0248	CbGeAlD
Propranolol—Terbinafine—CYP11A1—epilepsy syndrome	0.00015	0.102	CrCbGaD
Propranolol—ADRB1—telencephalon—epilepsy syndrome	0.000147	0.0233	CbGeAlD
Propranolol—HTR1A—brainstem—epilepsy syndrome	0.000142	0.0226	CbGeAlD
Propranolol—HTR1A—forebrain—epilepsy syndrome	0.000137	0.0218	CbGeAlD
Propranolol—CYP2D6—hindbrain—epilepsy syndrome	0.000135	0.0214	CbGeAlD
Propranolol—HTR1A—telencephalon—epilepsy syndrome	0.000126	0.02	CbGeAlD
Propranolol—ORM1—spinal cord—epilepsy syndrome	0.000117	0.0185	CbGeAlD
Propranolol—HTR1B—midbrain—epilepsy syndrome	0.000112	0.0178	CbGeAlD
Propranolol—HTR1B—spinal cord—epilepsy syndrome	0.000109	0.0174	CbGeAlD
Propranolol—ORM1—nervous system—epilepsy syndrome	9.84e-05	0.0156	CbGeAlD
Propranolol—HTR1B—head—epilepsy syndrome	9.73e-05	0.0155	CbGeAlD
Propranolol—ORM1—central nervous system—epilepsy syndrome	9.47e-05	0.015	CbGeAlD
Propranolol—HTR1B—nervous system—epilepsy syndrome	9.22e-05	0.0147	CbGeAlD
Propranolol—ADRB1—head—epilepsy syndrome	9.15e-05	0.0145	CbGeAlD
Propranolol—HTR1A—midbrain—epilepsy syndrome	9.05e-05	0.0144	CbGeAlD
Propranolol—HTR1B—central nervous system—epilepsy syndrome	8.88e-05	0.0141	CbGeAlD
Propranolol—HTR1A—spinal cord—epilepsy syndrome	8.83e-05	0.014	CbGeAlD
Propranolol—ADRB1—nervous system—epilepsy syndrome	8.68e-05	0.0138	CbGeAlD
Propranolol—ADRB1—central nervous system—epilepsy syndrome	8.35e-05	0.0133	CbGeAlD
Propranolol—Naphazoline—ADRA2A—epilepsy syndrome	7.9e-05	0.0538	CrCbGaD
Propranolol—HTR1A—head—epilepsy syndrome	7.85e-05	0.0125	CbGeAlD
Propranolol—CYP2D6—brainstem—epilepsy syndrome	7.71e-05	0.0123	CbGeAlD
Propranolol—CYP2D6—forebrain—epilepsy syndrome	7.44e-05	0.0118	CbGeAlD
Propranolol—HTR1A—nervous system—epilepsy syndrome	7.44e-05	0.0118	CbGeAlD
Propranolol—HTR1A—central nervous system—epilepsy syndrome	7.16e-05	0.0114	CbGeAlD
Propranolol—HTR1B—brain—epilepsy syndrome	7.05e-05	0.0112	CbGeAlD
Propranolol—HTR1A—cerebellum—epilepsy syndrome	7e-05	0.0111	CbGeAlD
Propranolol—CYP2D6—telencephalon—epilepsy syndrome	6.84e-05	0.0109	CbGeAlD
Propranolol—ADRB1—brain—epilepsy syndrome	6.63e-05	0.0105	CbGeAlD
Propranolol—CYP1A1—head—epilepsy syndrome	5.9e-05	0.00938	CbGeAlD
Propranolol—Carvedilol—VEGFA—epilepsy syndrome	5.82e-05	0.0396	CrCbGaD
Propranolol—Terbinafine—CYP2C19—epilepsy syndrome	5.72e-05	0.0389	CrCbGaD
Propranolol—HTR1A—brain—epilepsy syndrome	5.69e-05	0.00904	CbGeAlD
Propranolol—CYP1A1—nervous system—epilepsy syndrome	5.6e-05	0.00889	CbGeAlD
Propranolol—CYP1A1—central nervous system—epilepsy syndrome	5.39e-05	0.00856	CbGeAlD
Propranolol—ABCB1—forebrain—epilepsy syndrome	5.35e-05	0.00851	CbGeAlD
Propranolol—Carteolol—CYP2D6—epilepsy syndrome	5.2e-05	0.0354	CrCbGaD
Propranolol—ABCB1—telencephalon—epilepsy syndrome	4.92e-05	0.00782	CbGeAlD
Propranolol—Duloxetine—SLC6A4—epilepsy syndrome	4.55e-05	0.0309	CrCbGaD
Propranolol—CYP1A1—brain—epilepsy syndrome	4.28e-05	0.00679	CbGeAlD
Propranolol—CYP2D6—head—epilepsy syndrome	4.26e-05	0.00677	CbGeAlD
Propranolol—Metoprolol—CYP2C19—epilepsy syndrome	4.25e-05	0.0289	CrCbGaD
Propranolol—Terbinafine—CYP2D6—epilepsy syndrome	4.24e-05	0.0288	CrCbGaD
Propranolol—Ranolazine—CYP2D6—epilepsy syndrome	4.24e-05	0.0288	CrCbGaD
Propranolol—CYP3A4—nervous system—epilepsy syndrome	4.11e-05	0.00652	CbGeAlD
Propranolol—Betaxolol—CYP2D6—epilepsy syndrome	4.08e-05	0.0277	CrCbGaD
Propranolol—Cinacalcet—CYP2D6—epilepsy syndrome	4.08e-05	0.0277	CrCbGaD
Propranolol—CYP2D6—nervous system—epilepsy syndrome	4.04e-05	0.00642	CbGeAlD
Propranolol—CYP3A4—central nervous system—epilepsy syndrome	3.95e-05	0.00628	CbGeAlD
Propranolol—Bisoprolol—CYP2D6—epilepsy syndrome	3.94e-05	0.0268	CrCbGaD
Propranolol—Carvedilol—ADRA2A—epilepsy syndrome	3.9e-05	0.0265	CrCbGaD
Propranolol—CYP2D6—central nervous system—epilepsy syndrome	3.89e-05	0.00618	CbGeAlD
Propranolol—ABCB1—medulla oblongata—epilepsy syndrome	3.87e-05	0.00615	CbGeAlD
Propranolol—CYP2D6—cerebellum—epilepsy syndrome	3.8e-05	0.00604	CbGeAlD
Propranolol—Acebutolol—CYP2D6—epilepsy syndrome	3.73e-05	0.0254	CrCbGaD
Propranolol—Oxprenolol—CYP2D6—epilepsy syndrome	3.7e-05	0.0252	CrCbGaD
Propranolol—ABCB1—midbrain—epilepsy syndrome	3.54e-05	0.00562	CbGeAlD
Propranolol—Duloxetine—HTR2A—epilepsy syndrome	3.49e-05	0.0238	CrCbGaD
Propranolol—ABCB1—spinal cord—epilepsy syndrome	3.45e-05	0.00548	CbGeAlD
Propranolol—Alprenolol—CYP2D6—epilepsy syndrome	3.39e-05	0.023	CrCbGaD
Propranolol—Erythema multiforme—Gabapentin—epilepsy syndrome	3.33e-05	0.000473	CcSEcCtD
Propranolol—Vertigo—Valproic Acid—epilepsy syndrome	3.33e-05	0.000472	CcSEcCtD
Propranolol—Asthenia—Vigabatrin—epilepsy syndrome	3.31e-05	0.00047	CcSEcCtD
Propranolol—Decreased appetite—Lamotrigine—epilepsy syndrome	3.31e-05	0.000469	CcSEcCtD
Propranolol—Infestation NOS—Topiramate—epilepsy syndrome	3.31e-05	0.000469	CcSEcCtD
Propranolol—Infestation—Topiramate—epilepsy syndrome	3.31e-05	0.000469	CcSEcCtD
Propranolol—Urticaria—Clonazepam—epilepsy syndrome	3.3e-05	0.000468	CcSEcCtD
Propranolol—Depression—Topiramate—epilepsy syndrome	3.3e-05	0.000468	CcSEcCtD
Propranolol—Dizziness—Midazolam—epilepsy syndrome	3.29e-05	0.000466	CcSEcCtD
Propranolol—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	3.28e-05	0.000466	CcSEcCtD
Propranolol—Abdominal pain—Clonazepam—epilepsy syndrome	3.28e-05	0.000466	CcSEcCtD
Propranolol—Body temperature increased—Clonazepam—epilepsy syndrome	3.28e-05	0.000466	CcSEcCtD
Propranolol—Fatigue—Lamotrigine—epilepsy syndrome	3.28e-05	0.000465	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Topiramate—epilepsy syndrome	3.28e-05	0.000465	CcSEcCtD
Propranolol—Urticaria—Phenytoin—epilepsy syndrome	3.28e-05	0.000465	CcSEcCtD
Propranolol—Cardiac disorder—Gabapentin—epilepsy syndrome	3.27e-05	0.000464	CcSEcCtD
Propranolol—Asthenia—Diazepam—epilepsy syndrome	3.26e-05	0.000463	CcSEcCtD
Propranolol—Body temperature increased—Phenytoin—epilepsy syndrome	3.26e-05	0.000462	CcSEcCtD
Propranolol—Urticaria—Oxcarbazepine—epilepsy syndrome	3.26e-05	0.000462	CcSEcCtD
Propranolol—Constipation—Lamotrigine—epilepsy syndrome	3.25e-05	0.000462	CcSEcCtD
Propranolol—Pain—Lamotrigine—epilepsy syndrome	3.25e-05	0.000462	CcSEcCtD
Propranolol—Nausea—Acetazolamide—epilepsy syndrome	3.25e-05	0.000461	CcSEcCtD
Propranolol—Dizziness—Levetiracetam—epilepsy syndrome	3.25e-05	0.000461	CcSEcCtD
Propranolol—Abdominal pain—Oxcarbazepine—epilepsy syndrome	3.24e-05	0.00046	CcSEcCtD
Propranolol—Body temperature increased—Oxcarbazepine—epilepsy syndrome	3.24e-05	0.00046	CcSEcCtD
Propranolol—Diarrhoea—Fosphenytoin—epilepsy syndrome	3.24e-05	0.00046	CcSEcCtD
Propranolol—Cough—Valproic Acid—epilepsy syndrome	3.23e-05	0.000459	CcSEcCtD
Propranolol—Vomiting—Propofol—epilepsy syndrome	3.23e-05	0.000458	CcSEcCtD
Propranolol—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	3.22e-05	0.000457	CcSEcCtD
Propranolol—Rash—Propofol—epilepsy syndrome	3.2e-05	0.000454	CcSEcCtD
Propranolol—Dermatitis—Propofol—epilepsy syndrome	3.2e-05	0.000454	CcSEcCtD
Propranolol—Duloxetine—CYP2D6—epilepsy syndrome	3.2e-05	0.0217	CrCbGaD
Propranolol—Hypersensitivity—Zonisamide—epilepsy syndrome	3.17e-05	0.00045	CcSEcCtD
Propranolol—Vomiting—Midazolam—epilepsy syndrome	3.16e-05	0.000448	CcSEcCtD
Propranolol—Diarrhoea—Vigabatrin—epilepsy syndrome	3.16e-05	0.000448	CcSEcCtD
Propranolol—Asthenia—Felbamate—epilepsy syndrome	3.16e-05	0.000448	CcSEcCtD
Propranolol—Metoprolol—CYP2D6—epilepsy syndrome	3.15e-05	0.0214	CrCbGaD
Propranolol—Rash—Midazolam—epilepsy syndrome	3.13e-05	0.000445	CcSEcCtD
Propranolol—Dizziness—Fosphenytoin—epilepsy syndrome	3.13e-05	0.000444	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	3.13e-05	0.000444	CcSEcCtD
Propranolol—Dermatitis—Midazolam—epilepsy syndrome	3.13e-05	0.000444	CcSEcCtD
Propranolol—Urticaria—Carbamazepine—epilepsy syndrome	3.13e-05	0.000444	CcSEcCtD
Propranolol—Vomiting—Levetiracetam—epilepsy syndrome	3.12e-05	0.000443	CcSEcCtD
Propranolol—Alopecia—Gabapentin—epilepsy syndrome	3.12e-05	0.000442	CcSEcCtD
Propranolol—Abdominal pain—Carbamazepine—epilepsy syndrome	3.11e-05	0.000441	CcSEcCtD
Propranolol—Body temperature increased—Carbamazepine—epilepsy syndrome	3.11e-05	0.000441	CcSEcCtD
Propranolol—Diarrhoea—Diazepam—epilepsy syndrome	3.11e-05	0.000441	CcSEcCtD
Propranolol—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	3.11e-05	0.000441	CcSEcCtD
Propranolol—Rash—Levetiracetam—epilepsy syndrome	3.09e-05	0.000439	CcSEcCtD
Propranolol—Dermatitis—Levetiracetam—epilepsy syndrome	3.09e-05	0.000439	CcSEcCtD
Propranolol—Asthenia—Zonisamide—epilepsy syndrome	3.09e-05	0.000438	CcSEcCtD
Propranolol—Mental disorder—Gabapentin—epilepsy syndrome	3.09e-05	0.000438	CcSEcCtD
Propranolol—CYP2D6—brain—epilepsy syndrome	3.09e-05	0.00491	CbGeAlD
Propranolol—Agranulocytosis—Topiramate—epilepsy syndrome	3.08e-05	0.000438	CcSEcCtD
Propranolol—Agitation—Pregabalin—epilepsy syndrome	3.08e-05	0.000437	CcSEcCtD
Propranolol—Erythema—Gabapentin—epilepsy syndrome	3.07e-05	0.000436	CcSEcCtD
Propranolol—ABCB1—head—epilepsy syndrome	3.07e-05	0.00487	CbGeAlD
Propranolol—Hypersensitivity—Clonazepam—epilepsy syndrome	3.06e-05	0.000434	CcSEcCtD
Propranolol—Dizziness—Vigabatrin—epilepsy syndrome	3.05e-05	0.000433	CcSEcCtD
Propranolol—Hypersensitivity—Phenytoin—epilepsy syndrome	3.04e-05	0.000431	CcSEcCtD
Propranolol—Anaphylactic shock—Valproic Acid—epilepsy syndrome	3.02e-05	0.000429	CcSEcCtD
Propranolol—Urticaria—Lamotrigine—epilepsy syndrome	3.02e-05	0.000429	CcSEcCtD
Propranolol—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	3.02e-05	0.000429	CcSEcCtD
Propranolol—Bradycardia—Topiramate—epilepsy syndrome	3.02e-05	0.000429	CcSEcCtD
Propranolol—Nausea—Propofol—epilepsy syndrome	3.02e-05	0.000428	CcSEcCtD
Propranolol—Vomiting—Fosphenytoin—epilepsy syndrome	3.01e-05	0.000427	CcSEcCtD
Propranolol—Diarrhoea—Felbamate—epilepsy syndrome	3.01e-05	0.000427	CcSEcCtD
Propranolol—Vertigo—Pregabalin—epilepsy syndrome	3.01e-05	0.000427	CcSEcCtD
Propranolol—Abdominal pain—Lamotrigine—epilepsy syndrome	3.01e-05	0.000427	CcSEcCtD
Propranolol—Body temperature increased—Lamotrigine—epilepsy syndrome	3.01e-05	0.000427	CcSEcCtD
Propranolol—Dizziness—Diazepam—epilepsy syndrome	3.01e-05	0.000427	CcSEcCtD
Propranolol—Infection—Valproic Acid—epilepsy syndrome	3e-05	0.000426	CcSEcCtD
Propranolol—Rash—Fosphenytoin—epilepsy syndrome	2.99e-05	0.000424	CcSEcCtD
Propranolol—Dermatitis—Fosphenytoin—epilepsy syndrome	2.98e-05	0.000423	CcSEcCtD
Propranolol—Asthenia—Clonazepam—epilepsy syndrome	2.98e-05	0.000423	CcSEcCtD
Propranolol—Nervous system disorder—Valproic Acid—epilepsy syndrome	2.96e-05	0.000421	CcSEcCtD
Propranolol—Asthenia—Phenytoin—epilepsy syndrome	2.96e-05	0.00042	CcSEcCtD
Propranolol—Nausea—Midazolam—epilepsy syndrome	2.95e-05	0.000419	CcSEcCtD
Propranolol—Hallucination—Topiramate—epilepsy syndrome	2.95e-05	0.000419	CcSEcCtD
Propranolol—Diarrhoea—Zonisamide—epilepsy syndrome	2.95e-05	0.000418	CcSEcCtD
Propranolol—Pharyngitis—Topiramate—epilepsy syndrome	2.94e-05	0.000418	CcSEcCtD
Propranolol—Asthenia—Oxcarbazepine—epilepsy syndrome	2.94e-05	0.000418	CcSEcCtD
Propranolol—Vomiting—Vigabatrin—epilepsy syndrome	2.94e-05	0.000417	CcSEcCtD
Propranolol—Skin disorder—Valproic Acid—epilepsy syndrome	2.94e-05	0.000417	CcSEcCtD
Propranolol—Cough—Pregabalin—epilepsy syndrome	2.92e-05	0.000415	CcSEcCtD
Propranolol—Nausea—Levetiracetam—epilepsy syndrome	2.92e-05	0.000414	CcSEcCtD
Propranolol—Pindolol—CYP2D6—epilepsy syndrome	2.91e-05	0.0198	CrCbGaD
Propranolol—Rash—Vigabatrin—epilepsy syndrome	2.91e-05	0.000413	CcSEcCtD
Propranolol—Dizziness—Felbamate—epilepsy syndrome	2.91e-05	0.000413	CcSEcCtD
Propranolol—Dermatitis—Vigabatrin—epilepsy syndrome	2.91e-05	0.000413	CcSEcCtD
Propranolol—ABCB1—nervous system—epilepsy syndrome	2.91e-05	0.00462	CbGeAlD
Propranolol—Convulsion—Pregabalin—epilepsy syndrome	2.9e-05	0.000412	CcSEcCtD
Propranolol—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.9e-05	0.000411	CcSEcCtD
Propranolol—Vomiting—Diazepam—epilepsy syndrome	2.89e-05	0.00041	CcSEcCtD
Propranolol—Atenolol—ABCB1—epilepsy syndrome	2.89e-05	0.0196	CrCbGaD
Propranolol—Rash—Diazepam—epilepsy syndrome	2.87e-05	0.000407	CcSEcCtD
Propranolol—Dermatitis—Diazepam—epilepsy syndrome	2.86e-05	0.000406	CcSEcCtD
Propranolol—Visual impairment—Topiramate—epilepsy syndrome	2.86e-05	0.000406	CcSEcCtD
Propranolol—Dizziness—Zonisamide—epilepsy syndrome	2.85e-05	0.000404	CcSEcCtD
Propranolol—Diarrhoea—Clonazepam—epilepsy syndrome	2.84e-05	0.000403	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.83e-05	0.000402	CcSEcCtD
Propranolol—Asthenia—Carbamazepine—epilepsy syndrome	2.82e-05	0.000401	CcSEcCtD
Propranolol—Agitation—Gabapentin—epilepsy syndrome	2.82e-05	0.0004	CcSEcCtD
Propranolol—Diarrhoea—Phenytoin—epilepsy syndrome	2.82e-05	0.0004	CcSEcCtD
Propranolol—Nausea—Fosphenytoin—epilepsy syndrome	2.81e-05	0.000399	CcSEcCtD
Propranolol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.81e-05	0.000398	CcSEcCtD
Propranolol—Erythema multiforme—Topiramate—epilepsy syndrome	2.81e-05	0.000398	CcSEcCtD
Propranolol—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.8e-05	0.000398	CcSEcCtD
Propranolol—ABCB1—central nervous system—epilepsy syndrome	2.8e-05	0.00445	CbGeAlD
Propranolol—Vomiting—Felbamate—epilepsy syndrome	2.8e-05	0.000397	CcSEcCtD
Propranolol—Rash—Felbamate—epilepsy syndrome	2.77e-05	0.000394	CcSEcCtD
Propranolol—Dermatitis—Felbamate—epilepsy syndrome	2.77e-05	0.000393	CcSEcCtD
Propranolol—Vertigo—Gabapentin—epilepsy syndrome	2.76e-05	0.000391	CcSEcCtD
Propranolol—Cardiac disorder—Topiramate—epilepsy syndrome	2.75e-05	0.000391	CcSEcCtD
Propranolol—Dizziness—Clonazepam—epilepsy syndrome	2.74e-05	0.000389	CcSEcCtD
Propranolol—Nausea—Vigabatrin—epilepsy syndrome	2.74e-05	0.000389	CcSEcCtD
Propranolol—Vomiting—Zonisamide—epilepsy syndrome	2.74e-05	0.000389	CcSEcCtD
Propranolol—ABCB1—cerebellum—epilepsy syndrome	2.73e-05	0.00435	CbGeAlD
Propranolol—Insomnia—Valproic Acid—epilepsy syndrome	2.73e-05	0.000388	CcSEcCtD
Propranolol—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.73e-05	0.000388	CcSEcCtD
Propranolol—Asthenia—Lamotrigine—epilepsy syndrome	2.73e-05	0.000387	CcSEcCtD
Propranolol—Dizziness—Phenytoin—epilepsy syndrome	2.73e-05	0.000387	CcSEcCtD
Propranolol—Rash—Zonisamide—epilepsy syndrome	2.72e-05	0.000385	CcSEcCtD
Propranolol—Infection—Pregabalin—epilepsy syndrome	2.71e-05	0.000385	CcSEcCtD
Propranolol—Paraesthesia—Valproic Acid—epilepsy syndrome	2.71e-05	0.000385	CcSEcCtD
Propranolol—Dermatitis—Zonisamide—epilepsy syndrome	2.71e-05	0.000385	CcSEcCtD
Propranolol—Dizziness—Oxcarbazepine—epilepsy syndrome	2.71e-05	0.000385	CcSEcCtD
Propranolol—Nausea—Diazepam—epilepsy syndrome	2.7e-05	0.000383	CcSEcCtD
Propranolol—Dyspnoea—Valproic Acid—epilepsy syndrome	2.69e-05	0.000382	CcSEcCtD
Propranolol—Diarrhoea—Carbamazepine—epilepsy syndrome	2.69e-05	0.000382	CcSEcCtD
Propranolol—Somnolence—Valproic Acid—epilepsy syndrome	2.69e-05	0.000381	CcSEcCtD
Propranolol—Nervous system disorder—Pregabalin—epilepsy syndrome	2.68e-05	0.00038	CcSEcCtD
Propranolol—Cough—Gabapentin—epilepsy syndrome	2.68e-05	0.00038	CcSEcCtD
Propranolol—Acebutolol—ABCB1—epilepsy syndrome	2.66e-05	0.0181	CrCbGaD
Propranolol—Dyspepsia—Valproic Acid—epilepsy syndrome	2.66e-05	0.000377	CcSEcCtD
Propranolol—Convulsion—Gabapentin—epilepsy syndrome	2.66e-05	0.000377	CcSEcCtD
Propranolol—Skin disorder—Pregabalin—epilepsy syndrome	2.65e-05	0.000377	CcSEcCtD
Propranolol—Vomiting—Clonazepam—epilepsy syndrome	2.64e-05	0.000374	CcSEcCtD
Propranolol—Decreased appetite—Valproic Acid—epilepsy syndrome	2.63e-05	0.000373	CcSEcCtD
Propranolol—Alopecia—Topiramate—epilepsy syndrome	2.62e-05	0.000372	CcSEcCtD
Propranolol—Vomiting—Phenytoin—epilepsy syndrome	2.62e-05	0.000372	CcSEcCtD
Propranolol—Rash—Clonazepam—epilepsy syndrome	2.62e-05	0.000371	CcSEcCtD
Propranolol—Dermatitis—Clonazepam—epilepsy syndrome	2.61e-05	0.000371	CcSEcCtD
Propranolol—Nausea—Felbamate—epilepsy syndrome	2.61e-05	0.000371	CcSEcCtD
Propranolol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.61e-05	0.00037	CcSEcCtD
Propranolol—Vomiting—Oxcarbazepine—epilepsy syndrome	2.61e-05	0.00037	CcSEcCtD
Propranolol—Fatigue—Valproic Acid—epilepsy syndrome	2.61e-05	0.00037	CcSEcCtD
Propranolol—Dizziness—Carbamazepine—epilepsy syndrome	2.6e-05	0.000369	CcSEcCtD
Propranolol—Diarrhoea—Lamotrigine—epilepsy syndrome	2.6e-05	0.000369	CcSEcCtD
Propranolol—Rash—Phenytoin—epilepsy syndrome	2.6e-05	0.000369	CcSEcCtD
Propranolol—Mental disorder—Topiramate—epilepsy syndrome	2.6e-05	0.000369	CcSEcCtD
Propranolol—Dermatitis—Phenytoin—epilepsy syndrome	2.6e-05	0.000369	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	2.6e-05	0.000368	CcSEcCtD
Propranolol—Rash—Oxcarbazepine—epilepsy syndrome	2.59e-05	0.000367	CcSEcCtD
Propranolol—Pain—Valproic Acid—epilepsy syndrome	2.58e-05	0.000367	CcSEcCtD
Propranolol—Constipation—Valproic Acid—epilepsy syndrome	2.58e-05	0.000367	CcSEcCtD
Propranolol—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.58e-05	0.000367	CcSEcCtD
Propranolol—Erythema—Topiramate—epilepsy syndrome	2.58e-05	0.000366	CcSEcCtD
Propranolol—Nausea—Zonisamide—epilepsy syndrome	2.56e-05	0.000363	CcSEcCtD
Propranolol—Dizziness—Lamotrigine—epilepsy syndrome	2.52e-05	0.000357	CcSEcCtD
Propranolol—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.51e-05	0.000356	CcSEcCtD
Propranolol—Vomiting—Carbamazepine—epilepsy syndrome	2.5e-05	0.000355	CcSEcCtD
Propranolol—Infection—Gabapentin—epilepsy syndrome	2.49e-05	0.000353	CcSEcCtD
Propranolol—Rash—Carbamazepine—epilepsy syndrome	2.48e-05	0.000352	CcSEcCtD
Propranolol—Dermatitis—Carbamazepine—epilepsy syndrome	2.48e-05	0.000352	CcSEcCtD
Propranolol—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.47e-05	0.000351	CcSEcCtD
Propranolol—Insomnia—Pregabalin—epilepsy syndrome	2.47e-05	0.000351	CcSEcCtD
Propranolol—Nausea—Clonazepam—epilepsy syndrome	2.47e-05	0.00035	CcSEcCtD
Propranolol—Nervous system disorder—Gabapentin—epilepsy syndrome	2.46e-05	0.000349	CcSEcCtD
Propranolol—Paraesthesia—Pregabalin—epilepsy syndrome	2.45e-05	0.000348	CcSEcCtD
Propranolol—Nausea—Phenytoin—epilepsy syndrome	2.45e-05	0.000347	CcSEcCtD
Propranolol—Dyspnoea—Pregabalin—epilepsy syndrome	2.44e-05	0.000346	CcSEcCtD
Propranolol—Nausea—Oxcarbazepine—epilepsy syndrome	2.44e-05	0.000346	CcSEcCtD
Propranolol—Skin disorder—Gabapentin—epilepsy syndrome	2.43e-05	0.000345	CcSEcCtD
Propranolol—Somnolence—Pregabalin—epilepsy syndrome	2.43e-05	0.000345	CcSEcCtD
Propranolol—Vomiting—Lamotrigine—epilepsy syndrome	2.42e-05	0.000343	CcSEcCtD
Propranolol—Urticaria—Valproic Acid—epilepsy syndrome	2.4e-05	0.000341	CcSEcCtD
Propranolol—Rash—Lamotrigine—epilepsy syndrome	2.4e-05	0.00034	CcSEcCtD
Propranolol—Dermatitis—Lamotrigine—epilepsy syndrome	2.4e-05	0.00034	CcSEcCtD
Propranolol—Body temperature increased—Valproic Acid—epilepsy syndrome	2.39e-05	0.000339	CcSEcCtD
Propranolol—Abdominal pain—Valproic Acid—epilepsy syndrome	2.39e-05	0.000339	CcSEcCtD
Propranolol—Atomoxetine—SLC6A4—epilepsy syndrome	2.38e-05	0.0162	CrCbGaD
Propranolol—Decreased appetite—Pregabalin—epilepsy syndrome	2.38e-05	0.000337	CcSEcCtD
Propranolol—Agitation—Topiramate—epilepsy syndrome	2.37e-05	0.000337	CcSEcCtD
Propranolol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.36e-05	0.000335	CcSEcCtD
Propranolol—Fatigue—Pregabalin—epilepsy syndrome	2.36e-05	0.000334	CcSEcCtD
Propranolol—Nausea—Carbamazepine—epilepsy syndrome	2.34e-05	0.000332	CcSEcCtD
Propranolol—Pain—Pregabalin—epilepsy syndrome	2.34e-05	0.000332	CcSEcCtD
Propranolol—Constipation—Pregabalin—epilepsy syndrome	2.34e-05	0.000332	CcSEcCtD
Propranolol—Propafenone—CYP2D6—epilepsy syndrome	2.32e-05	0.0158	CrCbGaD
Propranolol—Vertigo—Topiramate—epilepsy syndrome	2.32e-05	0.000329	CcSEcCtD
Propranolol—Insomnia—Gabapentin—epilepsy syndrome	2.27e-05	0.000322	CcSEcCtD
Propranolol—Nausea—Lamotrigine—epilepsy syndrome	2.26e-05	0.000321	CcSEcCtD
Propranolol—Atomoxetine—CYP2C19—epilepsy syndrome	2.26e-05	0.0154	CrCbGaD
Propranolol—Cough—Topiramate—epilepsy syndrome	2.25e-05	0.00032	CcSEcCtD
Propranolol—Paraesthesia—Gabapentin—epilepsy syndrome	2.25e-05	0.000319	CcSEcCtD
Propranolol—Metoprolol—ABCB1—epilepsy syndrome	2.25e-05	0.0153	CrCbGaD
Propranolol—Convulsion—Topiramate—epilepsy syndrome	2.24e-05	0.000318	CcSEcCtD
Propranolol—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.23e-05	0.000317	CcSEcCtD
Propranolol—Dyspnoea—Gabapentin—epilepsy syndrome	2.23e-05	0.000317	CcSEcCtD
Propranolol—Somnolence—Gabapentin—epilepsy syndrome	2.23e-05	0.000316	CcSEcCtD
Propranolol—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.23e-05	0.000316	CcSEcCtD
Propranolol—ABCB1—brain—epilepsy syndrome	2.22e-05	0.00353	CbGeAlD
Propranolol—Dyspepsia—Gabapentin—epilepsy syndrome	2.21e-05	0.000313	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.18e-05	0.00031	CcSEcCtD
Propranolol—Decreased appetite—Gabapentin—epilepsy syndrome	2.18e-05	0.000309	CcSEcCtD
Propranolol—Urticaria—Pregabalin—epilepsy syndrome	2.17e-05	0.000308	CcSEcCtD
Propranolol—Asthenia—Valproic Acid—epilepsy syndrome	2.17e-05	0.000308	CcSEcCtD
Propranolol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.16e-05	0.000307	CcSEcCtD
Propranolol—Fatigue—Gabapentin—epilepsy syndrome	2.16e-05	0.000307	CcSEcCtD
Propranolol—Abdominal pain—Pregabalin—epilepsy syndrome	2.16e-05	0.000306	CcSEcCtD
Propranolol—Body temperature increased—Pregabalin—epilepsy syndrome	2.16e-05	0.000306	CcSEcCtD
Propranolol—Pain—Gabapentin—epilepsy syndrome	2.14e-05	0.000304	CcSEcCtD
Propranolol—Constipation—Gabapentin—epilepsy syndrome	2.14e-05	0.000304	CcSEcCtD
Propranolol—Infection—Topiramate—epilepsy syndrome	2.09e-05	0.000297	CcSEcCtD
Propranolol—Carvedilol—CYP2D6—epilepsy syndrome	2.09e-05	0.0142	CrCbGaD
Propranolol—Diarrhoea—Valproic Acid—epilepsy syndrome	2.07e-05	0.000293	CcSEcCtD
Propranolol—Nervous system disorder—Topiramate—epilepsy syndrome	2.07e-05	0.000293	CcSEcCtD
Propranolol—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.05e-05	0.000291	CcSEcCtD
Propranolol—Skin disorder—Topiramate—epilepsy syndrome	2.05e-05	0.000291	CcSEcCtD
Propranolol—Hypersensitivity—Pregabalin—epilepsy syndrome	2.01e-05	0.000286	CcSEcCtD
Propranolol—Dizziness—Valproic Acid—epilepsy syndrome	2e-05	0.000284	CcSEcCtD
Propranolol—Urticaria—Gabapentin—epilepsy syndrome	1.99e-05	0.000282	CcSEcCtD
Propranolol—Abdominal pain—Gabapentin—epilepsy syndrome	1.98e-05	0.000281	CcSEcCtD
Propranolol—Body temperature increased—Gabapentin—epilepsy syndrome	1.98e-05	0.000281	CcSEcCtD
Propranolol—Asthenia—Pregabalin—epilepsy syndrome	1.96e-05	0.000278	CcSEcCtD
Propranolol—Vomiting—Valproic Acid—epilepsy syndrome	1.92e-05	0.000273	CcSEcCtD
Propranolol—Insomnia—Topiramate—epilepsy syndrome	1.91e-05	0.000271	CcSEcCtD
Propranolol—Rash—Valproic Acid—epilepsy syndrome	1.91e-05	0.00027	CcSEcCtD
Propranolol—Dermatitis—Valproic Acid—epilepsy syndrome	1.9e-05	0.00027	CcSEcCtD
Propranolol—Paraesthesia—Topiramate—epilepsy syndrome	1.89e-05	0.000269	CcSEcCtD
Propranolol—Dyspnoea—Topiramate—epilepsy syndrome	1.88e-05	0.000267	CcSEcCtD
Propranolol—Somnolence—Topiramate—epilepsy syndrome	1.87e-05	0.000266	CcSEcCtD
Propranolol—Diarrhoea—Pregabalin—epilepsy syndrome	1.87e-05	0.000265	CcSEcCtD
Propranolol—Dyspepsia—Topiramate—epilepsy syndrome	1.86e-05	0.000263	CcSEcCtD
Propranolol—Hypersensitivity—Gabapentin—epilepsy syndrome	1.85e-05	0.000262	CcSEcCtD
Propranolol—Decreased appetite—Topiramate—epilepsy syndrome	1.83e-05	0.00026	CcSEcCtD
Propranolol—Atomoxetine—HTR2A—epilepsy syndrome	1.83e-05	0.0124	CrCbGaD
Propranolol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.82e-05	0.000258	CcSEcCtD
Propranolol—Fatigue—Topiramate—epilepsy syndrome	1.82e-05	0.000258	CcSEcCtD
Propranolol—Dizziness—Pregabalin—epilepsy syndrome	1.81e-05	0.000256	CcSEcCtD
Propranolol—Constipation—Topiramate—epilepsy syndrome	1.8e-05	0.000256	CcSEcCtD
Propranolol—Pain—Topiramate—epilepsy syndrome	1.8e-05	0.000256	CcSEcCtD
Propranolol—Asthenia—Gabapentin—epilepsy syndrome	1.8e-05	0.000255	CcSEcCtD
Propranolol—Nausea—Valproic Acid—epilepsy syndrome	1.8e-05	0.000255	CcSEcCtD
Propranolol—Vomiting—Pregabalin—epilepsy syndrome	1.74e-05	0.000247	CcSEcCtD
Propranolol—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.72e-05	0.000245	CcSEcCtD
Propranolol—Rash—Pregabalin—epilepsy syndrome	1.72e-05	0.000244	CcSEcCtD
Propranolol—Dermatitis—Pregabalin—epilepsy syndrome	1.72e-05	0.000244	CcSEcCtD
Propranolol—Diarrhoea—Gabapentin—epilepsy syndrome	1.71e-05	0.000243	CcSEcCtD
Propranolol—Urticaria—Topiramate—epilepsy syndrome	1.67e-05	0.000238	CcSEcCtD
Propranolol—Atomoxetine—CYP2D6—epilepsy syndrome	1.67e-05	0.0114	CrCbGaD
Propranolol—Abdominal pain—Topiramate—epilepsy syndrome	1.67e-05	0.000236	CcSEcCtD
Propranolol—Body temperature increased—Topiramate—epilepsy syndrome	1.67e-05	0.000236	CcSEcCtD
Propranolol—Propafenone—ABCB1—epilepsy syndrome	1.66e-05	0.0113	CrCbGaD
Propranolol—Dizziness—Gabapentin—epilepsy syndrome	1.66e-05	0.000235	CcSEcCtD
Propranolol—Nausea—Pregabalin—epilepsy syndrome	1.62e-05	0.00023	CcSEcCtD
Propranolol—Vomiting—Gabapentin—epilepsy syndrome	1.59e-05	0.000226	CcSEcCtD
Propranolol—Rash—Gabapentin—epilepsy syndrome	1.58e-05	0.000224	CcSEcCtD
Propranolol—Dermatitis—Gabapentin—epilepsy syndrome	1.58e-05	0.000224	CcSEcCtD
Propranolol—Hypersensitivity—Topiramate—epilepsy syndrome	1.55e-05	0.00022	CcSEcCtD
Propranolol—Asthenia—Topiramate—epilepsy syndrome	1.51e-05	0.000215	CcSEcCtD
Propranolol—Carvedilol—ABCB1—epilepsy syndrome	1.49e-05	0.0102	CrCbGaD
Propranolol—Nausea—Gabapentin—epilepsy syndrome	1.49e-05	0.000211	CcSEcCtD
Propranolol—Diarrhoea—Topiramate—epilepsy syndrome	1.44e-05	0.000205	CcSEcCtD
Propranolol—Dizziness—Topiramate—epilepsy syndrome	1.39e-05	0.000198	CcSEcCtD
Propranolol—Vomiting—Topiramate—epilepsy syndrome	1.34e-05	0.00019	CcSEcCtD
Propranolol—Rash—Topiramate—epilepsy syndrome	1.33e-05	0.000189	CcSEcCtD
Propranolol—Dermatitis—Topiramate—epilepsy syndrome	1.33e-05	0.000188	CcSEcCtD
Propranolol—Nausea—Topiramate—epilepsy syndrome	1.25e-05	0.000178	CcSEcCtD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.5e-06	4.14e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	1.49e-06	4.12e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	1.49e-06	4.11e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	1.49e-06	4.11e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	1.49e-06	4.11e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.48e-06	4.1e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—TH—epilepsy syndrome	1.48e-06	4.1e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	1.48e-06	4.09e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	1.47e-06	4.07e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.46e-06	4.03e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	1.46e-06	4.03e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.45e-06	4.01e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	1.45e-06	4e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—RELA—epilepsy syndrome	1.45e-06	4e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	1.44e-06	3.99e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PRKCB—epilepsy syndrome	1.44e-06	3.99e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	1.44e-06	3.98e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL6ST—epilepsy syndrome	1.44e-06	3.97e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	1.43e-06	3.96e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.43e-06	3.94e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	1.43e-06	3.94e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—MTOR—epilepsy syndrome	1.42e-06	3.92e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—AGT—epilepsy syndrome	1.42e-06	3.92e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	1.42e-06	3.91e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—AGT—epilepsy syndrome	1.42e-06	3.91e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	1.41e-06	3.9e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	1.41e-06	3.89e-05	CbGpPWpGaD
Propranolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.4e-06	3.88e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.4e-06	3.86e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	1.4e-06	3.86e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.39e-06	3.85e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—APOE—epilepsy syndrome	1.39e-06	3.84e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	1.39e-06	3.83e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—APOE—epilepsy syndrome	1.39e-06	3.83e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.39e-06	3.83e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	1.39e-06	3.83e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	1.38e-06	3.81e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	1.38e-06	3.81e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	1.38e-06	3.8e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.37e-06	3.77e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.36e-06	3.76e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.36e-06	3.76e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.36e-06	3.75e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	1.35e-06	3.72e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	1.34e-06	3.7e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.33e-06	3.68e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.33e-06	3.67e-05	CbGpPWpGaD
Propranolol—ADRB3—GPCR downstream signaling—AKT1—epilepsy syndrome	1.32e-06	3.64e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	1.32e-06	3.64e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—POMC—epilepsy syndrome	1.32e-06	3.63e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	1.31e-06	3.62e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	1.31e-06	3.62e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—HMOX1—epilepsy syndrome	1.31e-06	3.62e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.31e-06	3.61e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—CASP3—epilepsy syndrome	1.31e-06	3.61e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	1.3e-06	3.58e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CAT—epilepsy syndrome	1.29e-06	3.57e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—BCHE—epilepsy syndrome	1.29e-06	3.56e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CCL2—epilepsy syndrome	1.29e-06	3.55e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	1.28e-06	3.54e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	1.28e-06	3.54e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.27e-06	3.51e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—JUN—epilepsy syndrome	1.27e-06	3.5e-05	CbGpPWpGaD
Propranolol—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.27e-06	3.5e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	1.27e-06	3.49e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—BCHE—epilepsy syndrome	1.26e-06	3.48e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ABCB1—epilepsy syndrome	1.26e-06	3.47e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.26e-06	3.46e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	1.25e-06	3.44e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	1.24e-06	3.44e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	1.24e-06	3.42e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—MMP9—epilepsy syndrome	1.24e-06	3.41e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	1.23e-06	3.4e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—CAT—epilepsy syndrome	1.22e-06	3.37e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	1.22e-06	3.37e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	1.22e-06	3.37e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	1.22e-06	3.36e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	1.22e-06	3.36e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.21e-06	3.35e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—TH—epilepsy syndrome	1.21e-06	3.35e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	1.2e-06	3.32e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling by GPCR—AKT1—epilepsy syndrome	1.2e-06	3.31e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.2e-06	3.3e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	1.2e-06	3.3e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—POMC—epilepsy syndrome	1.19e-06	3.3e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	1.19e-06	3.29e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.19e-06	3.29e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—POMC—epilepsy syndrome	1.19e-06	3.29e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	1.19e-06	3.29e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	1.19e-06	3.29e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.19e-06	3.28e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	1.19e-06	3.28e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.19e-06	3.28e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—TH—epilepsy syndrome	1.19e-06	3.27e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.18e-06	3.27e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.18e-06	3.25e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—GPX1—epilepsy syndrome	1.17e-06	3.23e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	1.17e-06	3.23e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.17e-06	3.22e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	1.17e-06	3.22e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—FGF2—epilepsy syndrome	1.16e-06	3.21e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	1.15e-06	3.17e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.15e-06	3.17e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.15e-06	3.17e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	1.15e-06	3.16e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	1.14e-06	3.15e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—SRC—epilepsy syndrome	1.14e-06	3.14e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.13e-06	3.13e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	1.13e-06	3.11e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.12e-06	3.09e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	1.12e-06	3.09e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—TH—epilepsy syndrome	1.12e-06	3.08e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—VEGFA—epilepsy syndrome	1.11e-06	3.06e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—GPX1—epilepsy syndrome	1.11e-06	3.05e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.1e-06	3.04e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.1e-06	3.02e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—ALB—epilepsy syndrome	1.09e-06	3.01e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—ALB—epilepsy syndrome	1.09e-06	3e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—RELA—epilepsy syndrome	1.08e-06	2.98e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.06e-06	2.94e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.06e-06	2.93e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MTOR—epilepsy syndrome	1.06e-06	2.92e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	1.05e-06	2.89e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—AGT—epilepsy syndrome	1.03e-06	2.83e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	1.03e-06	2.83e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	1.03e-06	2.83e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	1.01e-06	2.8e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.01e-06	2.79e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.01e-06	2.78e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—APOE—epilepsy syndrome	1e-06	2.77e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	1e-06	2.77e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	1e-06	2.77e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CAT—epilepsy syndrome	1e-06	2.76e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—HMOX1—epilepsy syndrome	9.89e-07	2.73e-05	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—AKT1—epilepsy syndrome	9.83e-07	2.71e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	9.81e-07	2.71e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CAT—epilepsy syndrome	9.76e-07	2.69e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CASP3—epilepsy syndrome	9.74e-07	2.69e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	9.73e-07	2.68e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—AGT—epilepsy syndrome	9.69e-07	2.67e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	9.6e-07	2.65e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PTGS2—epilepsy syndrome	9.53e-07	2.63e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	9.51e-07	2.63e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	9.5e-07	2.62e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—APOE—epilepsy syndrome	9.49e-07	2.62e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—JUN—epilepsy syndrome	9.46e-07	2.61e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—TH—epilepsy syndrome	9.46e-07	2.61e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	9.37e-07	2.59e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	9.32e-07	2.57e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.31e-07	2.57e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	9.27e-07	2.56e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MMP9—epilepsy syndrome	9.21e-07	2.54e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CAT—epilepsy syndrome	9.2e-07	2.54e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	9.13e-07	2.52e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	9.08e-07	2.51e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	9.06e-07	2.5e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GPX1—epilepsy syndrome	9.04e-07	2.5e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	8.95e-07	2.47e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—AKT1—epilepsy syndrome	8.93e-07	2.46e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	8.86e-07	2.45e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GPX1—epilepsy syndrome	8.83e-07	2.44e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—POMC—epilepsy syndrome	8.63e-07	2.38e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	8.6e-07	2.37e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—SRC—epilepsy syndrome	8.49e-07	2.34e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	8.44e-07	2.33e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	8.41e-07	2.32e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GPX1—epilepsy syndrome	8.32e-07	2.3e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—VEGFA—epilepsy syndrome	8.27e-07	2.28e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	8.25e-07	2.28e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	8.23e-07	2.27e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	8.19e-07	2.26e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—POMC—epilepsy syndrome	8.16e-07	2.25e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	8.07e-07	2.23e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—AGT—epilepsy syndrome	7.93e-07	2.19e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	7.9e-07	2.18e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ALB—epilepsy syndrome	7.87e-07	2.17e-05	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	7.83e-07	2.16e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	7.8e-07	2.15e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CAT—epilepsy syndrome	7.79e-07	2.15e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—APOE—epilepsy syndrome	7.77e-07	2.14e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—BCHE—epilepsy syndrome	7.77e-07	2.14e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	7.76e-07	2.14e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—AGT—epilepsy syndrome	7.74e-07	2.14e-05	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	7.66e-07	2.11e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	7.59e-07	2.09e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—APOE—epilepsy syndrome	7.58e-07	2.09e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	7.58e-07	2.09e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	7.54e-07	2.08e-05	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	7.49e-07	2.07e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ALB—epilepsy syndrome	7.44e-07	2.05e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	7.42e-07	2.05e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	7.41e-07	2.04e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	7.37e-07	2.03e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	7.33e-07	2.02e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	7.33e-07	2.02e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—TH—epilepsy syndrome	7.3e-07	2.02e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—AGT—epilepsy syndrome	7.29e-07	2.01e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	7.21e-07	1.99e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	7.17e-07	1.98e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—APOE—epilepsy syndrome	7.15e-07	1.97e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	7.11e-07	1.96e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—AKT1—epilepsy syndrome	7.08e-07	1.95e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GPX1—epilepsy syndrome	7.05e-07	1.94e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	7.01e-07	1.94e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	6.96e-07	1.92e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PTGS2—epilepsy syndrome	6.89e-07	1.9e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	6.8e-07	1.88e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	6.76e-07	1.87e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—POMC—epilepsy syndrome	6.67e-07	1.84e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	6.61e-07	1.82e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	6.58e-07	1.82e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—POMC—epilepsy syndrome	6.51e-07	1.8e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	6.51e-07	1.8e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	6.47e-07	1.78e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	6.44e-07	1.78e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	6.3e-07	1.74e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—AGT—epilepsy syndrome	6.18e-07	1.71e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—POMC—epilepsy syndrome	6.14e-07	1.69e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	6.09e-07	1.68e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ALB—epilepsy syndrome	6.09e-07	1.68e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—APOE—epilepsy syndrome	6.05e-07	1.67e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CAT—epilepsy syndrome	6.01e-07	1.66e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ALB—epilepsy syndrome	5.94e-07	1.64e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	5.85e-07	1.61e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ALB—epilepsy syndrome	5.6e-07	1.54e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GPX1—epilepsy syndrome	5.44e-07	1.5e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	5.32e-07	1.47e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—AKT1—epilepsy syndrome	5.27e-07	1.46e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—POMC—epilepsy syndrome	5.2e-07	1.44e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PTGS2—epilepsy syndrome	5.2e-07	1.43e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	4.9e-07	1.35e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—AKT1—epilepsy syndrome	4.79e-07	1.32e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—AKT1—epilepsy syndrome	4.78e-07	1.32e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AGT—epilepsy syndrome	4.77e-07	1.32e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ALB—epilepsy syndrome	4.74e-07	1.31e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—APOE—epilepsy syndrome	4.67e-07	1.29e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	4.2e-07	1.16e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	4.15e-07	1.14e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	4.11e-07	1.13e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	4.02e-07	1.11e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—POMC—epilepsy syndrome	4.01e-07	1.11e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ALB—epilepsy syndrome	3.66e-07	1.01e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—AKT1—epilepsy syndrome	3.46e-07	9.55e-06	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—AKT1—epilepsy syndrome	3.27e-07	9.02e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	3.2e-07	8.84e-06	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—AKT1—epilepsy syndrome	2.68e-07	7.38e-06	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—AKT1—epilepsy syndrome	2.61e-07	7.21e-06	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.46e-07	6.79e-06	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—AKT1—epilepsy syndrome	2.08e-07	5.75e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.61e-07	4.44e-06	CbGpPWpGaD
